You are here: Industry Insights > steroids

News List

Oral Steroids Increase Infection Risk in Inflammatory Disease drugs
June 25, 2019
Oral Steroids Increase Infection Risk in Inflammatory Disease.
Tamoxifen and raloxifene slow down the progression of muscular dystrophy europeanpharmaceuticalreview
March 22, 2018
Long-term treatment with selective estrogen receptor modulators improves muscle, respiratory, and skeletal function without weakening bone in new mouse studies…
Study of childhood asthma cautions against short-term high-dose treatment with steroids europeanpharmaceuticalreview
March 08, 2018
Researchers in the US have found that a common practice among physicians to increase the use of steroids for worsening symptoms of asthma in children may be associated with slowing a child’s rate of growth.
Steroids not effective for chest infections in non-asthmatic adults europeanpharmaceuticalreview
August 24, 2017
Oral steroids should not be used for treating acute lower respiratory tract infection in adults who don’t have asthma or other chronic lung disease…
Tocilizumab Beats Steroids for Controlling Blood Vessel Inflammation in Study drugs.com
July 27, 2017
The drug tocilizumab performs better than steroids in treating the most common form of blood vessel inflammation known as giant cell arteritis, a new study has shown.
New analyses reinforce the potential of Ultibro Breezhaler for COPD patients historically treated wi cphi-online
May 25, 2017
New analyses from the FLAME study suggest dual bronchodilator Ultibro Breezhaler provides similar or better efficacy versus steroid-containing therapies, regardless of blood eosinophil counts.